Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Precision Biosciences (DTIL) Assets Average (2019 - 2025)

Historic Assets Average for Precision Biosciences (DTIL) over the last 7 years, with Q3 2025 value amounting to $101.2 million.

  • Precision Biosciences' Assets Average fell 3655.13% to $101.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $101.2 million, marking a year-over-year decrease of 3655.13%. This contributed to the annual value of $148.1 million for FY2024, which is 2557.63% down from last year.
  • Per Precision Biosciences' latest filing, its Assets Average stood at $101.2 million for Q3 2025, which was down 3655.13% from $116.7 million recorded in Q2 2025.
  • In the past 5 years, Precision Biosciences' Assets Average registered a high of $284.4 million during Q3 2022, and its lowest value of $101.2 million during Q3 2025.
  • Moreover, its 5-year median value for Assets Average was $193.1 million (2023), whereas its average is $190.8 million.
  • Per our database at Business Quant, Precision Biosciences' Assets Average soared by 3758.94% in 2021 and then tumbled by 3917.32% in 2023.
  • Precision Biosciences' Assets Average (Quarter) stood at $219.3 million in 2021, then rose by 16.23% to $255.0 million in 2022, then tumbled by 36.43% to $162.1 million in 2023, then fell by 10.64% to $144.8 million in 2024, then plummeted by 30.11% to $101.2 million in 2025.
  • Its Assets Average was $101.2 million in Q3 2025, compared to $116.7 million in Q2 2025 and $130.4 million in Q1 2025.